PatientsLikeMe ™

MS
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
MS
Find out more about the PatientsLikeMe
MS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Generic Name: Bupropion XL
See also: Bupropion, Wellbutrin

What is Wellbutrin XL? Wellbutrin XL™, a brand name of Bupropion XL, is an extended release version of bupropion, a norepinephrine and dopamine reuptake inhibitor (NDRI) used to treat major depressive disorder, including seasonal affective disorder (SAD).

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

67 patients in the community are taking or have taken Wellbutrin XL.

Reason # Patients Percentage of patients
Depression 44 65%
Other 14 20%
Anxiety 6 8%
Fatigue 1 1%
disease-related symptoms 1 1%
General health 1 1%

Dosages

Based on the patients currently taking Wellbutrin XL.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 day 80 mg day 100 mg day 150 g day 150 mg day 200 mg day 300 mg day 300 day 350 mg day 400 mg day 450 mg day
  2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 14 Number of Patients: 14 1 Number of Patients: 1 36 Number of Patients: 36 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3  

Duration

How long current patients have been taking Wellbutrin XL or how long patients were taking Wellbutrin XL before stopping.

Currently taking Wellbutrin XL

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
2
5
6
14

Stopped taking Wellbutrin XL

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
1
2
1
Why Patients Stopped Taking Wellbutrin XL (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2 40% Did not seem to work: 40%
Expense 1 20% Expense: 20%
Personal research 1 20% Personal research: 20%
Other 1 20% Other: 20%
Course of treatment ended 1 20% Course of treatment ended: 20%


Back to top